Remedix

Friedrichsdorf, Germany Founded: 2016 • Age: 10 yrs Acquired By Axicorp
Narcotic analgesics are distributed by Remedix across Europe.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 4 Brand Intelligence

About Remedix

Remedix is a company based in Friedrichsdorf (Germany) founded in 2016 was acquired by Axicorp in February 2016. Remedix operates in a competitive market with competitors including Cardinal Health, GELITA and Life Radiopharma, among others.

  • Headquarter Friedrichsdorf, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Axicorp

    (Feb 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Remedix

Premium access

Detailed funding history for Remedix

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Remedix

Remedix has secured backing from 1 investor. Prominent investors backing the company include Axicorp.

All
Investor Description Founded Year Domain Location
OTC drugs are manufactured by Axicorp in Germany.
Locked Locked Locked
Premium access

Investor details for Remedix

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Remedix

Investments
Premium access

Investment portfolio details for Remedix

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Remedix

Premium access

Detailed financials for Remedix

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Remedix Comparisons

Remedix Primary company
Description
Narcotic analgesics are distributed by Remedix across Europe...
Location
Friedrichsdorf, Germany
Founded Year
2016
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Remedix

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Remedix

Remedix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, GELITA and Life Radiopharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Multiple healthcare products and services are provided to organizations.
Locked Locked Locked
Distributes pharmaceutical products to businesses and partners.
Locked Locked Locked
Supplies short-lived radiotracers for nuclear medical diagnostics and reliable delivery services.
Premium access

Detailed competitors of Remedix

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Remedix

Premium access

Complete news archive for Remedix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Remedix

Remedix was founded in 2016.

Remedix is headquartered in Friedrichsdorf, Germany. It is registered at Friedrichsdorf, Hessen, Germany.

Remedix was founded in 2016 and is located in Friedrichsdorf, Germany. Operations are focused on the distribution of narcotic analgesics within the pharmaceutical sector. Services include supply chain management for controlled substances, serving healthcare providers and pharmacies primarily in the European market. The company is owned by John Dale and maintains its online presence through the domain remedix.eu. Activities adhere to regulatory standards for handling narcotics.

Remedix's top competitors include Cardinal Health, GELITA and Life Radiopharma.

Remedix has 1 investor. Key investors include Axicorp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available